New From Kineticos

Media Coverage

February 22, 2024

Kineticos Portfolio Company, neuro42, receives FDA Clearance

neuro42, a Kineticos Portfolio Company, Receives FDA Clearance on Portable and Compact Brain MRI Scanner for Point of Care Imaging…

Media Coverage

December 2, 2021

Supporting Innovative Biotechs to Bring Cell and Gene Therapies to Market

Kineticos takes an immersive stance with their biotech engagements and investments, working closely in a collaborative effort with key leadership…

Media Coverage

May 22, 2020

Kineticos Disruptor Fund Leads Promaxo’s Series B-1 Funding Round

“The Kineticos Disruptor Fund is focused on investing with entrepreneur scientists in disruptive platform technologies in areas of large, unmet…